Woolson Daniel, VP and General Manager of Infusion Capital at ICU Medical (ICUI), has demonstrated a consistent pattern of selling activity in the company’s stock over the past two years, with no recorded purchases. According to SEC Form 4 filings, Daniel has executed 26 transactions totaling $2.69 million in sales, all involving ICUI shares. His most recent disposals occurred in March 2026, with sales of $162,975.75 and $83,160 on March 15 and March 8, respectively, alongside a larger $907,764 transaction on the same March 8 filing. These follow earlier sales in November 2025 ($441,364.32) and March 2024 ($77,732.76), reinforcing a clear divestment trend.
The transactions appear structured, with multiple filings clustered around mid-March in consecutive years—suggesting possible prearranged trading plans or scheduled vesting events. Notably, Daniel’s sales in March 2026 alone exceeded $1.15 million, marking an acceleration compared to prior years. While the filings include numerous "F" (tax withholding) and "M" (exercise of derivative security) codes, the absence of any "P" (open market purchase) codes underscores a one-sided disposition. The lack of buying activity, combined with repeated sales at varying price points, indicates a sustained reduction in his ICUI holdings rather than opportunistic trading.
AI-assisted summary